Effects of bacterial cell wall components (PAMPS) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α) and the chemokine receptor CCR2 by purified human blood monocytes

Journal of Endotoxin Research

Volumn 9, Issue 6, 2003, Pages 349-360

  Møller, Anne Sophie Wiborg ^a   Øvstebø, Reidun ^a   Westvik, Åse Brit ^a   Joø, Gun Britt ^a   Haug, Kari Bente F ^a   Kierulf, Peter ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; CALCIUM; CD14 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; LIPOARABINOMANNAN; LIPOTEICHOIC ACID; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RECEPTOR ANTIBODY; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 13; RECOMBINANT INTERLEUKIN 4; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANTIGEN ANTIBODY REACTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL CELL WALL; BINDING AFFINITY; CALCIUM CELL LEVEL; CELL CONTACT; CELL LEVEL; CELL SURFACE; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; IC 50; IMMUNOREGULATION; MONOCYTE; MYCOBACTERIUM; NEISSERIA MENINGITIDIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; PURIFICATION; STATISTICAL SIGNIFICANCE;

ANTIBODIES, MONOCLONAL; CELLS, CULTURED; CHEMOKINE CCL2; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; LIMULUS TEST; LIPOPOLYSACCHARIDES; MACROPHAGE INFLAMMATORY PROTEIN-1; MONOCYTES; RECEPTORS, CHEMOKINE; RECOMBINANT PROTEINS; RNA, MESSENGER;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; ESCHERICHIA COLI; MYCOBACTERIUM; NEGIBACTERIA; NEISSERIA; NEISSERIA MENINGITIDIS; POSIBACTERIA;

EID: 0347659175     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805103225002791     Document Type: Article

References (70)

1. Ross R. Atherosclerosis - an inflammatory disease [see comments]. N Engl J Med 1999; 340: 115-126.
2. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-314.
3. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 565-568.
4. Rollins BJ. Chemokines. Blood 1997; 90: 909-928.
5. Lu B, Rutledge BJ, Gu L et al. Abnormalities in monocyte recruitment and cytokine, expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 1998; 187: 601-608.
6. Cook DN, Beck MA, Coffman TM et al. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 1995; 269: 1583-1585.
7. Colotta F, Borre A, Wang JM et al. Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes. J Immunol 1992; 148: 760-765.
8. Van Damme J, Proost P, Put W et al. Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA. J Immunol 1994; 152: 5495-5502.
9. Wang ZM, Liu C, Dziarski R. Chemokines are the main proinflammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan, and endotoxin. J Biol Chem 2000; 275: 20260-20267.
10. Yano S, Yanagawa H, Nishioka Y et al. T helper 2 cytokines differently regulate monocyte chemoattractant protein-1 production by human peripheral blood monocytes and alveolar macrophages. J Immunol 1996; 157: 2660-2665.
11. Berkman N, John M, Roesems G et al. Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages. J Immunol 1995; 155: 4412-4418.
12. Standiford TJ, Kunkel SL, Liebler JM et al. Gene expression of macrophage inflammatory protein-1 alpha from human blood monocytes and alveolar macrophages is inhibited by interleukin-4. Am J Respir Cell Mol Biol 1993; 9: 192-198.
13. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998; 394: 894-897.
14. Yla-Herttuala S, Lipton BA, Rosenfeld ME et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991; 88: 5252-5256.
15. Koch AE, Kunkel SL, Harlow LA et al. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 1992; 90: 772-779.
16. Chensue SW, Warmington KS, Ruth JH et al. Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production. J Immunol 1996; 157: 4602-4608.
17. Verani A, Scarlatti G, Comar M et al. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J Exp Med 1997; 185: 805-816.
18. + T cells. Science 1995; 270: 1811-1815.
19. Nibbs RJ, Yang J, Landau NR et al. LD78beta, a non-allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity. J Biol Chem 1999; 274: 17478-17483.
20. Charo IF, Myers SJ, Herman A et al. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci USA 1994; 91: 2752-2756.
21. Tanaka S, Green SR, Quehenberger O. Differential expression of the isoforms for the monocyte chemoattractant protein-1 receptor, CCR2, in monocytes. Biochem Biophys Res Commun 2002; 290: 73-80.
22. Loetscher P, Seitz M, Baggiolini M et al. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 1996; 184: 569-577.
23. Frade JM, Mellado M, del Real G et al. Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells. J Immunol 1997; 159: 5576-5584.
24. Polentarutti N, Allavena P, Bianchi G et al. IL-2-regulated expression of the monocyte chemotactic protein-1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-kilobase transcript containing CCR2B and CCR2A sequences. J Immunol 1997; 158: 2689-2694.
25. Sozzani S, Luini W, Molino M et al. The signal transduction pathway involved in the migration induced by a monocyte chemotactic cytokine. J Immunol 1991; 147: 2215-2221.
26. Sozzani S, Molino M, Locati M et al. Receptor-activated calcium influx in human monocytes exposed to monocyte chemotactic protein-1 and related cytokines. J Immunol 1993; 150: 1544-1553.
27. Boring L, Gosling J, Chensue SW et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997; 100: 2552-2561.
28. Wang JM, Hishinuma A, Oppenheim JJ et al. Studies of binding and internalization of human recombinant monocyte chemotactic and activating factor (MCAF) by monocytic cells. Cytokine 1993; 5: 264-275.
29. Tangirala RK, Murao K, Quehenberger O. Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines. J Biol Chem 1997; 272: 8050-8056.
30. Penton-Rol G, Polentarutti N, Luini W et al. Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma. J Immunol 1998; 160: 3869-3873.
31. Kito K, Morishita K, Nishida K. MCP-1 receptor binding affinity is up-regulated by pre-stimulation with MCP-1 in an actin polymerization-dependent manner. J Leukoc Biol 2001; 69: 666-674.
32. Xu L, Khandaker MH, Barlic J et al. Identification of a novel mechanism for endotoxin-mediated down-modulation of CC chemokine receptor expression. Eur J Immunol 2000; 30: 227-235.
33. Sica A, Saccani A, Borsatti A et al. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med 1997; 185: 969-974.
34. Xu L, Rahimpour R, Ran L et al. Regulation of CCR2 chemokine receptor mRNA stability. J Leukoc Biol 1997; 62: 653-660.
35. Han KH, Tangirala RK, Green SR et al. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. Arterioscler Thromb Vasc Biol 1998; 18: 1983-1991.
36. Fantuzzi L, Borghi P, Ciolli V et al. Loss of CCR2 expression and functional response to monocyte chemotactic protein (MCP-1) during the differentiation of human monocytes: role of secreted MCP-1 in the regulation of the chemotactic response. Blood 1999; 94: 875-883.
37. D'Amico G, Frascaroli G, Bianchi G et al. Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat Immunol 2000; 1: 387-391.
38. Schwandner R, Dziarski R, Wesche H et al. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999; 274: 17406-17409.
39. Yoshimura A, Lien E, Ingalls RR et al. Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999; 163: 1-5.
40. Opitz B, Schroder NW, Spreitzer I et al. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappaB translocation. J Biol Chem 2001; 276: 22041-22047.
41. Hoshino K, Takeuchi O, Kawai T et al. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162: 3749-3752.
42. Moller AW, Haug KB, Ovstebo R et al. Non-mannose-capped lipoarabinomannan stimulates human peripheral monocytes to expression of the 'early immediate genes' tissue factor and tumor necrosis factor-alpha. Thromb Res 2001; 102: 273-283.
43. Hirschfeld M, Ma Y, Weis JH et al. Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J Immunol 2000; 165: 618-622.
44. Brandtzaeg P, Bryn K, Kierulf P et al. Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. J Clin Invest 1992; 89: 816-823.
45. Morath S, Geyer A, Spreitzer I et al. Structural decomposition and heterogeneity of commercial lipoteichoic acid preparations. Infect Immun 2002; 70: 938-944.
46. Morath S, Geyer A, Hartung T. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med 2001; 193: 393-397.
47. Osnes LT, Westvik AB, Kierulf P. Procoagulant and profibrinolytic activities of cryopreserved human monocytes. Thromb Res 1994; 76: 373-383.
48. Boyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol 1976; Suppl 5: 9-15.
49. Lund PK, Joo GB, Westvik AB et al. Isolation of monocytes from whole blood by density gradient centrifugation and counter-current elutriation followed by cryopreservation: six years' experience. Scand J Clin Lab Invest 2000; 60: 357-365.
50. Ovstebo R, Haug KB, Lande K et al. PCR-based calibration curves for studies of quantitative gene expression in human monocytes: development and evaluation. Clin Chem 2003; 49: 425-432.
51. Roche Molecular Biochemicals. Relative Quantification. LC-Technical Note 13/2001, 2001.
52. Brandtzaeg P, Øvstebø R, Kierulf P. In: Pollard AJ, Maiden MJC. (eds) Meningococcal Disease: Methods and Protocols. Totowa, NJ: Humana, 2001; 427-439.
53. Lien E, Sellati TJ, Yoshimura A et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999; 274: 33419-33425.
54. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84: 1045-1049.
55. Rollins BJ, Walz A, Baggiolini M. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 1991; 78: 1112-1116.
56. Morr M, Takeuchi O, Akira S et al. Differential recognition of structural details of bacterial lipopeptides by Toll-like receptors. Eur J Immunol 2002; 32: 3337-3347.
57. Olszyna DP, Pajkrt D, Lauw FN et al. Interleukin 10 inhibits the release of CC chemokines during human endotoxemia. J Infect Dis 2000; 181: 613-620.
58. Nibbs RJ, Graham GJ, Pragnell IB. Cytokines. New York: Academic Press, 1998; 467-488.
59. Ueda A, Ishigatsubo Y, Okubo T et al. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J Biol Chem 1997; 272: 31092-31099.
60. Grove M, Plumb M. C/EBP, NF-kappa B, and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein 1 alpha immediate-early gene. Mol Cell Biol 1993; 13: 5276-5289.
61. Brandtzaeg P, Bjerre A, Ovstebo R et al. Neisseria meningitidis lipopolysaccharides in human pathology. J Endotoxin Res 2001; 7:401-420.
62. Yano S, Sone S, Nishioka Y et al. Differential effects of anti-inflammatory cytokines (IL,4, IL-10 and IL- 13) on tumoricidal and chemotactic properties of human monocytes induced by monocyte chemotactic and activating factor. J Leukoc Biol 1995; 57: 303-309.
63. Szczepanik AM, Funes S, Petko W et al. IL-4, IL-10 and IL-13 modulate A beta(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J Neuroimmunol 2001; 113: 49-62.
64. Wang P, Wu P, Siegel MI et al. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995; 270: 9558-9563.
65. Ameixa C, Friedland JS. Down-regulation of interleukin-8 secretion from Mycobacterium tuberculosis-infected monocytes by interleukin-4 and -10 but not by interleukin-13. Infect Immun 2001; 69: 2470-2476.
66. Lentsch AB, Shanley TP, Sarma V et al. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. J Clin Invest 1997; 100: 2443-2448.
67. Means TK, Wang S, Lien E et al. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999; 163: 3920-3927.
68. Flo TH, Halaas O, Lien E et al . Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J Immunol 2000; 164: 2064-2069.
69. Ellingsen E, Morath S, Flo T et al. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14. Med Sci Monit 2002; 8: 149-156.
70. Zhou Y, Yang Y, Warr G et al. LPS down-regulates the expression of chemokine receptor CCR2 in mice and abolishes macrophage infiltration in acute inflammation. J Leukoc Biol 1999; 65: 265-269.